Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1576 AL 1590

Lecanemab: A Humanized Monoclonal Antibody for the Treatment of Early Alzheimer Disease

Park J, Simpson C, Patel K.

Ann Pharmacother. 2024 Oct;58(10):1045-1053. doi: 10.1177/10600280231218253. Epub 2023 Dec 14.

Lecanemab: More Questions Than Answers!

Kaur U, Reddy J, Tiwari A, Chakrabarti S, Chakrabarti SS.

Clin Drug Investig. 2024 Jan;44(1):1-10. doi: 10.1007/s40261-023-01331-1. Epub 2023 Dec 14.

Cancer drugs with high repositioning potential for Alzheimer's disease

Majeed J, Sabbagh MN, Kang MH, Lawrence JJ, Pruitt K, Bacus S, Reyna E, Brown M, Decourt B.

Expert Opin Emerg Drugs. 2023 Dec;28(4):311-332. doi: 10.1080/14728214.2023.2296079. Epub 2023 Dec 26.

Machine learning in Alzheimer's disease drug discovery and target identification

Geng C, Wang Z, Tang Y.

Ageing Res Rev. 2024 Jan;93:102172. doi: 10.1016/j.arr.2023.102172. Epub 2023 Dec 16.

Audiovisual gamma stimulation for the treatment of neurodegeneration

Blanco-Duque C, Chan D, Kahn MC, Murdock MH, Tsai LH.

J Intern Med. 2024 Feb;295(2):146-170. doi: 10.1111/joim.13755. Epub 2023 Dec 19.

Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities

Zang WB, Wei HL, Zhang WW, Ma W, Li J, Yao Y.

Eur J Med Chem. 2024 Feb 5;265:116070. doi: 10.1016/j.ejmech.2023.116070. Epub 2023 Dec 18.

Caspases in Alzheimer's Disease: Mechanism of Activation, Role, and Potential Treatment

Wójcik P, Jastrzębski MK, Zięba A, Matosiuk D, Kaczor AA.

Mol Neurobiol. 2024 Jul;61(7):4834-4853. doi: 10.1007/s12035-023-03847-1. Epub 2023 Dec 23.

Current Anti-Amyloid-β Therapy for Alzheimer's Disease Treatment: From Clinical Research to Nanomedicine

Zhao Z, Liu Y, Ruan S, Hu Y.

Int J Nanomedicine. 2023 Dec 20;18:7825-7845. doi: 10.2147/IJN.S444115. eCollection 2023.

[Russian experience in using a combination of fixed doses of donepezil and memantine in the treatment of Alzheimer's disease as an observational non-interventional multicenter program]

Kolykhalov IV, Mkhitaryan EA, Fedorova YB, Ponomareva EV, Selezneva ND, Cherdak MA, Dudchenko NG, Seyfedinova AB, Isaev RI, Gavrilova SI, Tkacheva ON.

Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(12):69-75. doi: 10.17116/jnevro202312312169.

Ferroptosis and its modulators: A raising target for cancer and Alzheimer's disease

Singh G, Kesharwani P, Kumar Singh G, Kumar S, Putta A, Modi G.

Bioorg Med Chem. 2024 Jan 15;98:117564. doi: 10.1016/j.bmc.2023.117564. Epub 2023 Dec 20.

Drug Repositioning of Pioglitazone in Management and Improving the Cognitive Function among the Patients With Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis

Basutkar RS, Sudarsan P, Robin SM, Bhaskar V, Viswanathan B, Sivasankaran P.

Neurol India. 2023 Nov-Dec;71(6):1132-1141. doi: 10.4103/0028-3886.391397.

Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives

Ayaz M, Mosa OF, Nawaz A, Hamdoon AAE, Elkhalifa MEM, Sadiq A, Ullah F, Ahmed A, Kabra A, Khan H, Murthy HCA.

Phytomedicine. 2024 Feb;124:155272. doi: 10.1016/j.phymed.2023.155272. Epub 2023 Dec 12.

Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease

Zhou X, Wu X, Wang R, Han L, Li H, Zhao W.

Int J Mol Sci. 2023 Dec 22;25(1):170. doi: 10.3390/ijms25010170.

Systematic review and meta‑analysis of observational studies to check the protective role of non‑steroidal anti‑inflammatory drugs in Alzheimer's disease

Asthana A, Tripathi S, Agarwal R.

Acta Neurobiol Exp (Wars). 2023 Dec 4;83(4):386-394. doi: 10.55782/ane-2023-2467.

The immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease

Ye Y, Gao M, Shi W, Gao Y, Li Y, Yang W, Zheng X, Lu X.

Front Immunol. 2024 Jan 8;14:1325530. doi: 10.3389/fimmu.2023.1325530. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias